Evolution of Approaches to Viral Safety Issues for Biological Products

Anthony S. Lubiniecki

doi:10.5731/pdajpst.2011.00818

OtherConference Proceeding

Evolution of Approaches to Viral Safety Issues for Biological Products

Anthony S. Lubiniecki

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 547-556; DOI: https://doi.org/10.5731/pdajpst.2011.00818

Anthony S. Lubiniecki

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
References
Info & Metrics
PDF

Article Information

vol. 65 no. 6 547-556

DOI

https://doi.org/10.5731/pdajpst.2011.00818

PubMed

22294576

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online January 4, 2012.

Author Information

Anthony S. Lubiniecki

Portfolio Management, Pharmaceutical Development & Manufacturing Sciences, Johnson & Johnson Pharmaceutical Research & Development, Malvern, PA 19355, USA

View Full Text

Cited By...

10 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes—Chapter 2a: source pigs—preventing xenozoonoses

Thomas Spizzo, Joachim Denner, Lawrence Gazda, Michael Martin, Divya Nathu, Linda Scobie, Yasuhiro Takeuchi

Xenotransplantation 2016 23 1
Adapting viral safety assurance strategies to continuous processing of biological products

Sarah A. Johnson, Matthew R. Brown, Scott C. Lute, Kurt A. Brorson

Biotechnology and Bioengineering 2017 114 1
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers

Nathan J. Roth, Herbert O. Dichtelmüller, Fabrizio Fabbrizzi, Eckhard Flechsig, Albrecht Gröner, Mary Gustafson, Juan I. Jorquera, Thomas R. Kreil, Dominika Misztela, Elisa Moretti, Mila Moscardini, Gerhard Poelsler, John More, Peter Roberts, Andreas Wieser, Rodrigo Gajardo

Transfusion 2020 60 11
Virus filtration: A review of current and future practices in bioprocessing

Sarah A. Johnson, Shuang Chen, Glen Bolton, Qi Chen, Scott Lute, John Fisher, Kurt Brorson

Biotechnology and Bioengineering 2022 119 3
The step-wise framework to design a chromatography-based hydrophobicity assay for viral particles

Sarah A. Johnson, Alison Walsh, Matthew R. Brown, Scott C. Lute, David J. Roush, Michael S. Burnham, Kurt A. Brorson

Journal of Chromatography B 2017 1061-1062
Effect of operating pressure on protein fouling during constant-pressure virus removal filtration

Joshua Peles, Fatemeh Fallahianbijan, Benjamin Cacace, Christina Carbrello, Sal Giglia, Andrew L. Zydney

Journal of Membrane Science 2022 648
Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics

Samadhi Vitharana, Joshua M. Stillahn, Derrick S. Katayama, Charles S. Henry, Mark Cornell Manning

Journal of Pharmaceutical Sciences 2023 112 11
Impact of proteins and protein fouling on virus retention during virus removal filtration

Mohammad A. Afzal, Andrew L. Zydney

Biotechnology and Bioengineering 2024 121 2
Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients

Miklós Udvardy, Árpád Illés, Lajos Gergely, László Imre Pinczés, Ferenc Magyari, Zsófia Simon

Pathogens 2023 12 7
Primary cell culture from the nose of a marine organism, the banded houndshark, Triakis scyllium

Sang-Myung Jung, Dae Seung Kim, Hwa Sung Shin

Biotechnology and Bioprocess Engineering 2013 18 2

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 65, Issue 6

November/December 2011

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Evolution of Approaches to Viral Safety Issues for Biological Products

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 8 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Evolution of Approaches to Viral Safety Issues for Biological Products

Anthony S. Lubiniecki

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 547-556; DOI: 10.5731/pdajpst.2011.00818

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Evolution of Approaches to Viral Safety Issues for Biological Products

Anthony S. Lubiniecki

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 547-556; DOI: 10.5731/pdajpst.2011.00818

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Conference Proceeding

Proceedings of the 2017 Viral Clearance Symposium, Session 1.1: Upstream Mitigation, Part 1—Cell Bank and Bulk Harvest Testing
Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing
Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations—Virus Filtration/Inactivation

Show more Conference Proceeding

Paper

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus
Evolution of Approaches to Viral Safety Issues for Biological Products
Broadening Our Expectations for Viral Safety Risk Mitigation

Show more Paper

Main menu

User menu

Search

Evolution of Approaches to Viral Safety Issues for Biological Products

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Conference Proceeding

Paper

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.